Skip to main content

Clinical Trials

Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.

What's new

Help researchers evaluate and improve gestational diabetes screening and diagnosis – share this clinical study with anyone you know who is newly pregnant to see if they are eligible to join. Continue Reading »

A remote six-month clinical trial is recruiting 150 children between the ages of two to five whose families are interested in trying automated insulin delivery. The study will evaluate the use of automated insulin delivery in young children to see if it improves Time in Range and other health metrics. Continue Reading »

The Your SAY: Hypoglycemia study is a 30-minute online survey that will help an international research team understand how severe low blood sugar affects quality of life – for people around the world living with type 1 diabetes, type 2 diabetes, and their loved ones. Continue Reading »

Calling all adults with prediabetes or type 2 diabetes: The T2Help study is recruiting 280 participants for a 16-week virtual clinical trial to collect continuous glucose monitor (CGM), activity tracker, and self-recorded health data.  Continue Reading »

A fully virtual six-month clinical trial is recruiting 300 people with type 1 and type 2 diabetes who are interested in trying continuous glucose monitoring (CGM) with personal support. The study will determine how access to virtual diabetes care with CGM impacts Time in Range (TIR). Continue Reading »

This clinical trial is currently recruiting – participants will be enrolled in one of two stress-intervention courses to measures changes in A1C, diabetes distress, and more. Continue Reading »

This clinical trial is currently recruiting. Families will participate in weekly sessions that focus on topics related to diabetes distress and parent-teen communication, with the hopes of improving Time in Range and lowering A1C levels in the teen with type 1 diabetes.  Continue Reading »

Vertex's new cell therapy, made from stem cells, aims to replace insulin-producing cells in people with type 1 diabetes. The therapy will soon begin testing in clinical trials to determine its safety and efficacy. Continue Reading »

Pages